LOGSX — Live Oak Health Sciences Fund
Data updated: 2026-06-29
LOGSX — Live Oak Health Sciences Fund. United States Multi-Cap / All-Cap Growth Health Care Equity · $49.52M AUM. Holdings, fees, performance and SEC filings.
LOGSX Fund Overview
LOGSX — Live Oak Health Sciences Fund is a US mutual fund managed by Oak Associates Funds, categorised as United States Multi-Cap / All-Cap Growth Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Oak Associates Funds
- Category: United States Multi-Cap / All-Cap Growth Health Care Equity
- Assets under management: $49.52M
- 1-year return: 14.1%
- Ticker: LOGSX
- SEC CIK: 0001050918
- SEC series ID: S000006542
- Share class ID: C000017877
LOGSX Holdings
Top 10 holdings of Live Oak Health Sciences Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| United Therapeutics Corp. | 6.40% |
| Cardinal Health, Inc. | 5.57% |
| Jazz Pharmaceuticals PLC | 5.25% |
| Novartis AG | 5.01% |
| Cencora, Inc. | 5.00% |
| Amgen, Inc. | 4.95% |
| Mount Vernon Liquid Assets Portfolio, LLC | 4.90% |
| Mckesson Corp. | 4.89% |
| Exelixis, Inc. | 4.71% |
| Regeneron Pharmaceuticals, Inc. | 4.66% |
LOGSX Portfolio Allocation
Asset-class allocation of Live Oak Health Sciences Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 96.8% |
| Cash & Equivalents | 8.1% |
LOGSX Performance
Total returns for LOGSX (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -1.3% |
| 1 year | 14.1% |
| 3 years (annualised) | 7.3% |
| 5 years (annualised) | 5.8% |
LOGSX Risk Information
Risk metrics for LOGSX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.0%
LOGSX Costs and Fees
LOGSX costs about $104 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.04%
- Gross expense ratio: 1.04%
- Portfolio turnover: 24%
- Brokerage commissions: 1.25 bps of average net assets (SEC N-CEN)
LOGSX Cashflows
Over the 12 months to 2026-04, Live Oak Health Sciences Fund had net outflows of $5.67M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | $13.98K |
| 2026-03 | $331.72K |
| 2026-02 | −$1.92M |
| 2026-01 | −$867.16K |
| 2025-12 | $1.03M |
| 2025-11 | −$2.66M |
LOGSX Debt Constituents
No individual debt constituents are reported in Live Oak Health Sciences Fund's latest SEC N-PORT filing.
LOGSX Prospectus and SEC Filings
Official Live Oak Health Sciences Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-02-27
- Prospectus (485BPOS) — filed 2025-02-28
- Prospectus (485BPOS) — filed 2024-02-28
- Portfolio holdings (N-PORT) — filed 2026-06-29
- Portfolio holdings (N-PORT) — filed 2026-04-01
- Portfolio holdings (N-PORT) — filed 2025-12-30
- Annual census (N-CEN) — filed 2026-01-08
- Annual census (N-CEN) — filed 2025-01-03
Related Funds
Other United States Multi-Cap / All-Cap Growth Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.